Germline Mutations in MAP3K6 Are Associated with Familial Gastric Cancer
Open Access
- 23 October 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 10 (10) , e1004669
Abstract
Gastric cancer is among the leading causes of cancer-related deaths worldwide. While heritable forms of gastric cancer are relatively rare, identifying the genes responsible for such cases can inform diagnosis and treatment for both hereditary and sporadic cases of gastric cancer. Mutations in the E-cadherin gene, CDH1, account for 40% of the most common form of familial gastric cancer (FGC), hereditary diffuse gastric cancer (HDGC). The genes responsible for the remaining forms of FGC are currently unknown. Here we examined a large family from Maritime Canada with FGC without CDH1 mutations, and identified a germline coding variant (p.P946L) in mitogen-activated protein kinase kinase kinase 6 (MAP3K6). Based on conservation, predicted pathogenicity and a known role of the gene in cancer predisposition, MAP3K6 was considered a strong candidate and was investigated further. Screening of an additional 115 unrelated individuals with non-CDH1 FGC identified the p.P946L MAP3K6 variant, as well as four additional coding variants in MAP3K6 (p.F849Sfs*142, p.P958T, p.D200Y and p.V207G). A somatic second-hit variant (p.H506Y) was present in DNA obtained from one of the tumor specimens, and evidence of DNA hypermethylation within the MAP3K6 gene was observed in DNA from the tumor of another affected individual. These findings, together with previous evidence from mouse models that MAP3K6 acts as a tumor suppressor, and studies showing the presence of somatic mutations in MAP3K6 in non-hereditary gastric cancers and gastric cancer cell lines, point towards MAP3K6 variants as a predisposing factor for FGC. The underlying genetic mutations involved in 60% of inherited gastric cancer cases remain unknown. Here we present a large, extended pedigree with familial gastric cancer and an association in part of the family with a mutation in MAP3K6. The conservation, predicted pathogenicity of the variant, tissue distribution, and known function of MAP3K6 made this a strong candidate that warranted further investigation. Examination of an additional 115 unrelated probands identified additional mutations in MAP3K6, including a truncating mutation.Keywords
This publication has 57 references indexed in Scilit:
- Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov ModelsHuman Mutation, 2012
- Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancerProceedings of the National Academy of Sciences, 2010
- A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variantsBritish Journal of Cancer, 2010
- A map of human genome variation from population-scale sequencingNature, 2010
- Integrating common and rare genetic variation in diverse human populationsNature, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Germline MutY Human Homologue Mutations and Colorectal Cancer: A Multisite Case-Control StudyGastroenterology, 2009
- ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesisThe EMBO Journal, 2009
- Patterns of somatic mutation in human cancer genomesNature, 2007
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006